John M. Hamlyn
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
John M. Hamlyn has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Mordecai P. Blaustein
Department of Physiology, University of Maryland School of Medicine, Baltimore, MD 21201, USA
2 shared publications - Frans H. H. Leenen
Brain and Heart Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada
1 shared publication - Hongwei Wang
Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
1 shared publication Mordecai P. Blaustein
University of Maryland Baltimore
1 shared publication- Shabnam Salimi
School of Medicine, University of Maryland, Baltimore, MD, USA
1 shared publication Terunao Ashida
University of Maryland Baltimore
1 shared publication
Latest Publications
- Open Access
- 1 April 2024
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 326 (4) , C1120-C1177
Sensational site: the sodium pump ouabain-binding site and its ligands
Cardiotonic steroids (CTS), used by certain insects, toads, and rats for protection from predators, became, thanks to Withering’s trailblazing 1785 monograph, the mainstay of heart failure (HF) therapy. In the 1950s and 1960s, we learned that the CTS receptor was part of the sodium pump (NKA) and that the Na+/Ca2+ exchanger was critical for the acute cardiotonic effect of digoxin- and ouabain-related CTS. This “settled” view was upended by seven revolutionary observations. First, subnanomolar ouabain sometimes stimulates NKA while higher concentrations are invariably inhibitory. Second, endogenous ouabain (EO) was discovered in the human circulation. Third, in the DIG clinical trial, digoxin only marginally improved outcomes in patients with HF. Fourth, cloning of NKA in 1985 revealed multiple NKA α and β subunit isoforms that, in the rodent, differ in their sensitivities to CTS. Fifth, the NKA is a cation pump and a hormone receptor/signal transducer. EO binding to NKA activates, in a ligand- and cell-specific manner, several protein kinase and Ca2+-dependent signaling cascades that have widespread physiological effects and can contribute to hypertension and HF pathogenesis. Sixth, all CTS are not equivalent, e.g., ouabain induces hypertension in rodents while digoxin is antihypertensinogenic (“biased signaling”). Seventh, most common rodent hypertension models require a highly ouabain-sensitive α2 NKA and the elevated blood pressure is alleviated by EO immunoneutralization. These numerous phenomena are enabled by NKA’s intricate structure. We have just begun to understand the endocrine role of the endogenous ligands and the broad impact of the ouabain-binding site on physiology and pathophysiology.
- 1 April 2024
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 326 (4) , C1120-C1177
Open AccessSensational site: the sodium pump ouabain-binding site and its ligands
Cardiotonic steroids (CTS), used by certain insects, toads, and rats for protection from predators, became, thanks to Withering’s trailblazing 1785 monograph, the mainstay of heart failure (HF) therapy. In the 1950s and 1960s, we learned that the CTS receptor was part of the sodium pump (NKA) and that the Na+/Ca2+ exchanger was critical for the acute cardiotonic effect of digoxin- and ouabain-related CTS. This “settled” view was upended by seven revolutionary observations. First, subnanomolar ouabain sometimes stimulates NKA while higher concentrations are invariably inhibitory. Second, endogenous ouabain (EO) was discovered in the human circulation. Third, in the DIG clinical trial, digoxin only marginally improved outcomes in patients with HF. Fourth, cloning of NKA in 1985 revealed multiple NKA α and β subunit isoforms that, in the rodent, differ in their sensitivities to CTS. Fifth, the NKA is a cation pump and a hormone receptor/signal transducer. EO binding to NKA activates, in a ligand- and cell-specific manner, several protein kinase and Ca2+-dependent signaling cascades that have widespread physiological effects and can contribute to hypertension and HF pathogenesis. Sixth, all CTS are not equivalent, e.g., ouabain induces hypertension in rodents while digoxin is antihypertensinogenic (“biased signaling”). Seventh, most common rodent hypertension models require a highly ouabain-sensitive α2 NKA and the elevated blood pressure is alleviated by EO immunoneutralization. These numerous phenomena are enabled by NKA’s intricate structure. We have just begun to understand the endocrine role of the endogenous ligands and the broad impact of the ouabain-binding site on physiology and pathophysiology.
- Open Access
- 16 May 2020
- Published by MDPI AG in Preprints.org
COVID-19 and Crosstalk With the Hallmarks of Aging
Within the past several decades, the emergence of new viral diseases with severe health complications and mortality is evidence of an age-dependent, compromised bodily response to abrupt stress with concomitantly reduced immunity. The new severe acute respiratory syndrome coronavirus 2, SARS-CoV-2, causes coronavirus disease 2019 (COVID-19). It has increased morbidity and mortality in persons with underlying chronic diseases and those with a compromised immune system regardless of age and in older adults who are more likely to have these conditions. While SARS-CoV-2 is highly virulent, there is variability in the severity of the disease and its complications in humans. Severe pneumonia, acute respiratory distress syndrome, lung fibrosis, cardiovascular events, acute kidney injury, stroke, hospitalization, and mortality have been reported that result from pathogen–host interactions. Hallmarks of aging, interacting with one another, have been proposed to influence health span in older adults, possibly via mechanisms regulating the immune system. Here, we review the potential roles of the hallmarks of aging coupled with host–coronavirus interactions. Of these hallmarks, we focused on those that directly or indirectly interact with viral infections, including immunosenescence, inflammation and inflammasomes, adaptive immunosenescence, genomic instability, mitochondrial dysfunction, telomere attrition, epigenetic alterations, and impaired autophagy. These hallmarks likely contribute to the increased pathophysiological responses to SARS-CoV-2 among older adults and may play roles as an additive risk of accelerated biological aging even after recovery. We also briefly discuss the role of anti-aging drug candidates that require paramount attention in COVID-19 research.
- 16 May 2020
- Published by MDPI AG in Preprints.org
Open AccessCOVID-19 and Crosstalk With the Hallmarks of Aging
Within the past several decades, the emergence of new viral diseases with severe health complications and mortality is evidence of an age-dependent, compromised bodily response to abrupt stress with concomitantly reduced immunity. The new severe acute respiratory syndrome coronavirus 2, SARS-CoV-2, causes coronavirus disease 2019 (COVID-19). It has increased morbidity and mortality in persons with underlying chronic diseases and those with a compromised immune system regardless of age and in older adults who are more likely to have these conditions. While SARS-CoV-2 is highly virulent, there is variability in the severity of the disease and its complications in humans. Severe pneumonia, acute respiratory distress syndrome, lung fibrosis, cardiovascular events, acute kidney injury, stroke, hospitalization, and mortality have been reported that result from pathogen–host interactions. Hallmarks of aging, interacting with one another, have been proposed to influence health span in older adults, possibly via mechanisms regulating the immune system. Here, we review the potential roles of the hallmarks of aging coupled with host–coronavirus interactions. Of these hallmarks, we focused on those that directly or indirectly interact with viral infections, including immunosenescence, inflammation and inflammasomes, adaptive immunosenescence, genomic instability, mitochondrial dysfunction, telomere attrition, epigenetic alterations, and impaired autophagy. These hallmarks likely contribute to the increased pathophysiological responses to SARS-CoV-2 among older adults and may play roles as an additive risk of accelerated biological aging even after recovery. We also briefly discuss the role of anti-aging drug candidates that require paramount attention in COVID-19 research.
- 1 March 2020
- Published by Elsevier in Cell Calcium
- Vol. 86, 102151
Sodium pumps, ouabain and aldosterone in the brain: A neuromodulatory pathway underlying salt-sensitive hypertension and heart failure
- 1 March 2020
- Published by Elsevier in Cell Calcium
- Vol. 86, 102151
Sodium pumps, ouabain and aldosterone in the brain: A neuromodulatory pathway underlying salt-sensitive hypertension and heart failure
- 1 September 2016
- Published by Wolters Kluwer Health in Hypertension
- Vol. 68 (3) , 526-532
Endogenous Ouabain
In this brief article, we summarize recent reports about endogenous ouabain (EO), a cardiotonic steroid (CTS). This includes analysis of mammalian EO, the discovery of EO isomers, regulation of intracellular signaling by EO, and the roles of EO in hypertension, pregnancy, and heart and kidney diseases. Novel ouabain-resistant mice that elucidate the key roles of α2 Na+ pumps and their CTS binding site are also discussed.
- 1 September 2016
- Published by Wolters Kluwer Health in Hypertension
- Vol. 68 (3) , 526-532
Endogenous Ouabain
In this brief article, we summarize recent reports about endogenous ouabain (EO), a cardiotonic steroid (CTS). This includes analysis of mammalian EO, the discovery of EO isomers, regulation of intracellular signaling by EO, and the roles of EO in hypertension, pregnancy, and heart and kidney diseases. Novel ouabain-resistant mice that elucidate the key roles of α2 Na+ pumps and their CTS binding site are also discussed.
- 1 November 1991
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 88 (21) , 9907d-9907
Corrections and Retraction: Identification and Characterization of a Ouabain-Like Compound from Human Plasma
- 1 November 1991
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 88 (21) , 9907d-9907
Corrections and Retraction: Identification and Characterization of a Ouabain-Like Compound from Human Plasma
- 1 December 1986
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 488 (1 Membrane) , 199-216
Sodium/Calcium Exchange in Vascular Smooth Muscle:.
- 1 December 1986
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 488 (1 Membrane) , 199-216
Sodium/Calcium Exchange in Vascular Smooth Muscle:.